Acute basilar artery occlusion: Endovascular Interventions versus Standard Medical Treatment (BEST) Trial—Design and protocol for a randomized,controlled,multicenter study

Abstract

Rationale

Endovascular treatment plus standard medical therapy is superior to standard medical therapy alone for acute anterior proximal intracranial large artery occlusion strokes. The benefit of endovascular treatment in acute ischemic stroke caused by basilar artery occlusion remains unproven.

Aim

This study compares the safety and efficacy of endovascular treatment plus standard medical therapy versus standard medical therapy alone in acute ischemic stroke due to basilar artery occlusion.

Design

The study is a multicenter randomized control trial with blinded outcome assessment. A projected total 344 subjects with acute basilar arterial occlusion within 8 h of estimated occlusion time will be enrolled over three years in China. Patients will be assigned to endovascular treatment plus standard medical therapy and standard medical therapy alone group in 1:1 ratio for study centers.

Study outcomes

The primary outcome measure is a favorable functional outcome, defined as a modified Rankin Score of 0–3 at 90 days. The primary safety measure is mortality at 90 days.

Trial registration

ClinicalTrials.gov (NCT 02441556).

Summary

The BEST trial will provide valuable insights into the safety and efficacy of endovascular treatment for acute ischemic stroke patients with basilar artery occlusion.

Keywords

Thrombectomy basilar artery stroke endovascular treatment randomized

Get full access to this article

View all access options for this article.

References

Schonewille

Wijman

Michel

et al.

Treatment and outcomes of acute basilar artery occlusion in the basilar artery international cooperation study (basics): a prospective registry study. Lancet Neurol 2009; 8: 724–730.

Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581–1587.

Hacke

Kaste

Bluhmki

et al.

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317–1329.

Saqqur

Uchino

Demchuk

et al.

Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948–954.

Ciccone

Valvassori

Nichelatti

et al.

Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904–913.

Broderick

Palesch

Demchuk

et al.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893–903.

Kidwell

Jahan

Gornbein

et al.

A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914–923.

Smith

Sung

Saver

et al.

Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205–1212.

Nogueira

Lutsep

Gupta

et al.

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380: 1231–1240.

10.

Saver

Jahan

Levy

et al.

Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241–1249.

11.

Berkhemer

Fransen

Beumer

et al.

A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11–20.

12.

Jovin

Chamorro

Cobo

et al.

Thrombectomy within 8 hours after symptom onset in 4ischemic stroke. N Engl J Med 2015; 372: 2296–2306.

13.

Saver

Goyal

Bonafe

et al.

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285–2295.

14.

Campbell

Mitchell

Kleinig

et al.

Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–1018.

15.

Goyal

Demchuk

Menon

et al.

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019–1030.

16.

Bracard

Ducrocq

Mas

et al.

Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016; 15: 1138–1147.

17.

Mattle

Arnold

Lindsberg

Schonewille

Schroth

. Basilar artery occlusion. Lancet Neurol 2011; 10: 1002–1014.

18.

Schonewille

Wijman

Michel

et al.

Treatment and outcomes of acute basilar artery occlusion inthe Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009; 8: 724–730.

19.

Jauch

Saver

Adams

et al.

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870–947.

20.

Puetz

Sylaja

Coutts

et al.

Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. Stroke 2008; 39: 2485–2490.

21.

Singer

Berkefeld

Nolte

et al.

Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol 2015; 77: 415–424.

22.

Van der Hoeven

Schonewille

Vos

et al.

The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial. Trials 2013; 14: 200.

23.

Saver

Goyal

van der Lugt

et al.

Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016; 316: 1279–1288.

24.

Ferbert

Bruckmann

Drummen

. Clinical features of proven basilar artery occlusion. Stroke 1990; 21: 1135–1142.